» Articles » PMID: 16911879

Comparison of Methylene Blue-directed Biopsies and Four-quadrant Biopsies in the Detection of High-grade Intraepithelial Neoplasia and Early Cancer in Barrett's Oesophagus

Overview
Journal Dig Liver Dis
Publisher Elsevier
Specialty Gastroenterology
Date 2006 Aug 17
PMID 16911879
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Barrett's oesophagus embodies the risk of malignant transformation. High-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus are often discrete or macroscopically occult lesions and show a patchy distribution and therefore, directed biopsies in combination with four-quadrant random biopsies are the gold standard for surveillance.

Aims: The aim of this prospective study was to compare methylene blue staining and random biopsies in patients with early Barrett's neoplasia.

Patients And Methods: Eighty-six patients (mean age 65+/-8 years) with histologically proven but macroscopically in evident high-grade intraepithelial neoplasia (n=17) or early cancer in Barrett's oesophagus (n=69) on HR-endoscopy with all together 98 lesions, were included. In the first step, four-quadrant random biopsies were taken during routine endoscopy (group I). In a second step, staining was performed with a 0.5% solution of methylene blue with a spray catheter. Biopsies of focal areas with decreased stain, heterogeneity of stain or absence stain were taken (group II).

Results: In 75/86 patients, high-grade intraepithelial neoplasia or early cancer in Barrett's oesophagus could be diagnosed in the methylene blue group while 56 patients were determined in the random biopsies group (P=0.053). High-grade intraepithelial neoplasia or early cancer was diagnosed in significantly more methylene blue-directed biopsies (80.9% versus 26.4%, P<0.005) and also significantly more lesions could be identified in the methylene blue group (96/98; 98%) while in the random biopsies group only 58/98 lesions (59%) could be localised (P<0.05). When methylene blue was used (1217 versus 562, P<0.0001), the average number of specimens taken with methylene blue per patient was about half of that with random biopsy (6.5 versus 14.1, P<0.0001).

Conclusions: Chromoendoscopy with methylene blue diagnosed significantly more patients and lesions with intraepithelial neoplasia or early cancer in Barrett's oesophagus compared to random biopsies. In addition, significantly less biopsies were needed with methylene blue compared to random biopsies. The use of methylene blue-directed biopsies appears to improve the detection of intraepithelial neoplasia and early cancer in Barrett's oesophagus.

Citing Articles

Role of endoscopy in early oesophageal cancer.

Mannath J, Ragunath K Nat Rev Gastroenterol Hepatol. 2016; 13(12):720-730.

PMID: 27807370 DOI: 10.1038/nrgastro.2016.148.


Barrett's esophagus in 2016: From pathophysiology to treatment.

Martinucci I, De Bortoli N, Russo S, Bertani L, Furnari M, Mokrowiecka A World J Gastrointest Pharmacol Ther. 2016; 7(2):190-206.

PMID: 27158534 PMC: 4848241. DOI: 10.4292/wjgpt.v7.i2.190.


Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.

Singh A, Chak A Gastroenterol Rep (Oxf). 2015; 3(4):303-15.

PMID: 26486568 PMC: 4650977. DOI: 10.1093/gastro/gov048.


Endoscopic assessment and management of early esophageal adenocarcinoma.

Hammoud G, Hammad H, Ibdah J World J Gastrointest Oncol. 2014; 6(8):275-88.

PMID: 25132925 PMC: 4133795. DOI: 10.4251/wjgo.v6.i8.275.


Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review.

Qumseya B, Wang H, Badie N, Uzomba R, Parasa S, White D Clin Gastroenterol Hepatol. 2013; 11(12):1562-70.e1-2.

PMID: 23851020 PMC: 3910269. DOI: 10.1016/j.cgh.2013.06.017.